Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

Depressive Disorders: Etiology

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Diagnostic and Statistical Manual of Mental Disorders (DSM)

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...

Classification of Illness

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe and...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Twin Study on the Relation Between Positive Mental Health and Biological Aging.

International journal of molecular sciences·2026

Same author

Compulsory admissions, mechanical restraints and staff attitudes toward coercion in a sample of psychiatric wards in Italy.

International journal of law and psychiatry·2026

Same author

Factors associated with major stressful life events in a 3-year naturalistic longitudinal screening of perinatal depression.

Asian journal of psychiatry·2026

Same author

Loneliness and Social Connectedness in Mental Health.

The International journal of social psychiatry·2026

Same author

Psychological profile of patients with Brugada syndrome and the impact of its diagnosis and management.

NPJ cardiovascular health·2026

Same author

From skin clearance to psychological wellbeing: real-world outcomes of biologic therapy in psoriasis.

Frontiers in psychology·2026

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis

Published on: May 10, 2022

Subtyping depression in the medically ill by cluster analysis.

Jenny Guidi¹, Giovanni A Fava, Angelo Picardi

¹Laboratory of Psychosomatics and Clinimetrics, Department of Psychology, University of Bologna, Bologna, Italy. jenny.guidi2@unibo.it

Journal of Affective Disorders

|April 5, 2011

Summary

This summary is machine-generated.

Subtyping major depressive disorder in medically ill patients revealed two distinct groups: somatizers and irritable/anxious depression. This highlights the need for broader assessment in psychosomatic research.

More Related Videos

A New Method for Inducing a Depression-Like Behavior in Rats

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

Related Experiment Videos

Last Updated: Jun 3, 2026

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis

Published on: May 10, 2022

A New Method for Inducing a Depression-Like Behavior in Rats

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Closed-Loop Neurostimulation for Biomarker-Driven, Personalized Treatment of Major Depressive Disorder

Published on: July 7, 2023

Area of Science:

Psychiatry and Psychosomatic Medicine
Clinical Psychology
Medical Sociology

Background:

Growing recognition of the need to subtype major depressive disorder (MDD), especially in patients with co-existing medical conditions.
Current diagnostic systems may not fully capture the heterogeneity of depression in medically ill populations.

Purpose of the Study:

To characterize depression in medically ill patients using both DSM-IV comorbidity and the Diagnostic Criteria for Psychosomatic Research (DCPR).
To identify distinct subtypes of depression within this patient group.

Main Methods:

Cross-sectional assessment of 1560 medically ill patients from the Italian Health System using DSM-IV and DCPR structured interviews.
Cluster analysis was performed on the 198 patients diagnosed with MDD.

Main Results:

Two distinct clusters of depression were identified: 'depressed somatizers' (58.6%) and 'irritable/anxious depression' (41.4%).
The somatizer cluster was associated with DCPR somatization syndromes and alexithymia.
The anxious/irritable cluster was linked to DCPR irritable mood, Type A behavior, and DSM-IV anxiety disorders.

Conclusions:

Findings suggest the importance of incorporating DCPR criteria, including somatization, irritable mood, Type A behavior, and alexithymia, into the clinical assessment of medically ill patients.
Subtyping MDD in this population may lead to more refined targets for psychosomatic research and clinical trials.